Lucas & Mercanti, LLP, Author at Lucas & Mercanti, LLP
April 21, 2026
April 21, 2026
Categories

Written Description and Enablement Requirements For Antibodies

Written Description and Enablement Requirements For Antibodies By Irving Feit Teva Pharmaceuticals International GmbH v. Eli Lilly and Company U.S. Court of Appeals for the Federal Circuit […]
Do you like it?
Read more
April 2, 2024
April 2, 2024
Categories

Why USPTO Should Issue Inherency Guidance Memo

Why USPTO Should Issue Inherency Guidance Memo By Irving Feit · Law360, April 2, 2024 From time to time, the U.S. Patent and Trademark Office issues guidance memos to […]
Do you like it?
Read more
January 1, 2023
January 1, 2023
Categories

Shintaro Yamada Elected to Partner

Lucas & Mercanti LLP is Pleased to Announce that Shintaro Yamada Has Been Elected to Partner January 1, 2023 | Lucas & Mercanti, LLP Mr. Yamada […]
Do you like it?
Read more